A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection

NCT01064752 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2010-02-08

No results posted yet for this study

Summary

This will be an uncontrolled, open-labelled pilot study exploring whether minocycline has a measurable and selective effect on HIV infection of the central nervous system.

Conditions

  • HIV Infection

Interventions

DRUG

Minocycline

100 mg po bid for 8 weeks

Sponsors & Collaborators

Principal Investigators

  • Richard W Price, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2009-10-31
Completion
2009-10-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01064752 on ClinicalTrials.gov